Adverse Drug Reactions in Elderly Hospitalized Patients: A 12-Year Population-Based Retrospective Cohort Study

Abstract

Spanish

French

BACKGROUND:

Although research has identified some risk factors for first-time adverse drug reactions (ADRs), little is known about the risks associated with the number of ADRs. Modeling ADR counts is relatively complex because of the rarity of the events, requiring careful consideration of appropriate models that best present the observed data.

OBJECTIVE:

To determine the incidence of ADRs among elderly hospitalized patients, assess patient-related risk factors for the number of ADRs, and review drug classes commonly responsible for ADRs.

METHODS:

This retrospective cohort study used a population-based large administrative database on hospital separations from all acute care hospitals in the Canadian province of Newfoundland and Labrador. Patients aged 65 years or older with at least 1 hospital admission from April 1, 1995, to March 31, 2007, were included. Comorbidities, Charlson Comorbidity Index (CCI), and sociodemographic factors were assessed as predictors of ADR counts. A zero-inflated negative binomial regression model was used for analysis.

RESULTS:

The study cohort contained 64,446 patients. The incidence of ADRs was 15.2 per 1000 person-years (95% CI 14.8 to 15.7). Of those having an ADR, 15.4% had recurrent ADRs. The most common drug category implicated in ADRs was cardiovascular agents (17.7%). A dose-response relationship was found between CCI and ADR counts (rate ratio [RR] 1.67, 95% CI 1.41 to 1.98 for CCI 2-3; RR 2.38, 95% CI 1.98 to 2.87 for CCI 4-5; and RR 3.83, 95% CI 3.21-4.57 for CCI ≥6). Comorbid conditions including congestive heart failure (RR 1.58, 95% CI 1.33 to 1.89), diabetes (RR 2.42, 95% CI 1.64 to 3.56), and cancer (RR 3.12, 95% CI 2.58 to 3.76) were strong predictors. Rural areas (RR 1.22, 95% CI 1.01 to 1.46) were associated with increased risk for ADRs, whereas age and sex had no effect.

CONCLUSIONS:

Comorbidity from chronic diseases and severity of illness, rather than individual characteristics (advancing age and sex), increased the likelihood of ADRs. Changes in the delivery of care focusing on the monitoring of prescribed drugs in elderly patients with comorbidities could mitigate ADRs.

Keywords

adverse drug reaction comorbid illness count data patient safety zero-inflated modeling

Get full access to this article

View all access options for this article.

References

Kohn

, Corrigan

, Donaldson

. To err is human: building a safer health system. Committee on Quality of Health Care in America, Institute of Medicine. Washington, DC: National Academy Press, 1999.

Bates

, Cullen

, Laird

, et al. Incidence of adverse drug events and potential adverse drug events. JAMA 1995; 274: 29–34.

Lazarou

, Pomeranz

, Corey

. Incidence of adverse drug reactions in hospitalized patients: a meta-analysis of prospective studies. JAMA 1998; 279: 1200–5.

Roughead

, Gilbert

, Primrose

, et al. Drug-related hospital admissions: a review of Australian studies published 1988-96. Med J Aust 1998; 168: 405–8.

McDonnell

, Jacobs

. Hospital admissions resulting from preventable adverse drug reactions. Ann Pharmacother 2002; 36: 1331–6. DOI: 10.1345/aph.1A333

Zhang

, Holman

CDJ

, Price

, et al. Comorbidity and repeat admission to hospital for adverse drug reactions in older adults: retrospective cohort study. BMJ 2009; 338: a2752. DOI: 10.1136/bmj.a2752

Baker

, Norton

, Flintoft

, et al. The Canadian adverse events study: the incidence of adverse events among hospital patients in Canada. CMAJ 2004; 170: 1678–86.

Statistics Canada. Census snapshot of Canada—population, age and sex. Canadian Social Trends 2007; 84: 37–8.

Canadian Institute of Health Information. Drug use among seniors on public drug programs in Canada, 2002-2008. Ottawa, Ontario: CIHI, 2010.

10.

Bates

. Drugs and adverse drug reactions: how worried should we be? JAMA 1998; 279: 1216–7.

11.

Field

, Gurwitz

, Avorn

, et al. Risk factors for adverse drug events among nursing home residents. Arch Intern Med 2001; 161: 1629–34.

12.

French

. Avoiding adverse drug reactions in the elderly patient: issues and strategies. Nurse Practitioner 1996; 21: 90–105.

13.

Fialová

, Topinková

, Gambassi

, et al. Potentially inappropriate medication use among elderly home care patients in Europe. JAMA 2005; 293: 1348–58.

14.

Onder

, Landi

, Vedova

, et al. Moderate alcohol consumption and adverse drug reactions among older adults. Pharmacoepidemiol Drug Saf 2002; 11: 385–92.

15.

Onder

, Penninx

, Landi

, et al. Depression and adverse drug reactions among hospitalized older adults. Arch Intern Med 2003; 163: 301–5.

16.

Chrischilles

, VanGilder

, Wright

, et al. Inappropriate medication use as a risk factor for self-reported adverse drug effects in older adults. J Am Geriatr Soc 2009; 57: 1000–6.

17.

Donaldson

, Sobolev

, Cook

, et al. Analysis of recurrent events: a systematic review of randomised controlled trials of interventions to prevent falls. Age Ageing 2009; 38: 151–5. DOI: 10.1093/ageing/afn279

18.

Glynn

, Buring

. Ways of measuring rates of recurrent events. BMJ 1996; 312: 364–7.

19.

Edwards

. Abnormal birth weight among term gestation infants in Newfoundland and Labrador: trends and determinants. Memorial University of Newfoundland (Canada). ProQuest Dissertations and Theses, 2008. http://search.proquest.com/docview/304404798?accountid=12378 (accessed 2012 Jun 14).

20.

Edwards

, Aronson

. Adverse drug reactions: definitions, diagnosis, and management. Lancet 2000; 356: 1255–9.

21.

Charlson

, Pompei

, Ales

, et al. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 1987; 40: 373–83.

22.

Sundararajan

, Henderson

, Perry

, et al. New ICD-10 version of the Charlson Comorbidity Index predicted in-hospital mortality. J Clin Epidemiol 2004; 57: 1288–94.

23.

Luthi

, Troillet

, Eisenring

, et al. Administrative data outperformed single-day chart review for comorbidity measure. Int J Qual Health Care 2007; 19: 225–31. DOI: 10.1093/intqhc/mzm017

24.

O'Connell

, Lim

LLY

. Utility of the Charlson Comorbidity Index computed from routinely collected hospital discharge diagnosis codes. Method Inform Med 2000; 39: 7–11.

25.

Engels

, Diehr

. Imputation of missing longitudinal data: a comparison of methods. J Clin Epidemiol 2003; 56: 968–76.

26.

Bohning

. A note on test for Poisson overdispersion. Biometrika 1994; 81: 418–9.

27.

Orme

, Combs-Orme

. Regression with a count variable. In: Multiple regression with discrete dependent variables. Oxford, England: Oxford University Press, 2009: 152–206.

28.

Vuong

. Likelihood ratio tests for model selection and non-nested hypothesis. Econometrica 1989; 57: 307–33.

29.

Everitt

. The Cambridge dictionary of statistics. 2nd ed. Cambridge, England: Cambridge University Press, 2002.

30.

Onder

, Pedone

, Landi

, et al. Adverse drug reactions as cause of hospital admissions: results from the Italian Group of Pharmacoepidemiology in the Elderly (GIFA). J Am Geriatr Soc 2002; 50: 1962–8.

31.

Alexopoulou

, Dourakis

, Mantzoukis

, et al. Adverse drug reactions as a cause of hospital admissions: a 6-month experience in a single center in Greece. Eur J Int Med 2008; 19: 505–10. DOI: 10.1016/j.ejim.2007.06.030

32.

Pouyanne

, Haramburu

, Imbs

, et al. Admissions to hospital caused by adverse drug reactions: cross sectional incidence study. French Pharmacovigilance Centres. BMJ 2000; 320: 1036.

33.

Sinha

, Raha

, Wilkins

. Adverse drug reactions and hospital admission of older patients. Age Ageing 2000; 29: 551–2.

34.

Sikdar

, Alaghehbandan

, MacDonald

, et al. Adverse drug events in adult patients leading to emergency department visits. Ann Pharmacother 2010; 44: 641–9. DOI: 10.1345/aph.1M416.

35.

Brennan

, Leape

, Laird

, et al. Incidence of adverse events and negligence in hospitalized patients. N Engl J Med 1991; 324: 370–6.

36.

Taché

, Sönnichsen

, Ashcroft

. Prevalence of adverse drug events in ambulatory care: a systematic review. Ann Pharmacother 2011; 45: 977–89. DOI: 10.1345/aph.1P627

37.

Chan

, Nicklason

, Vial

. Adverse drug events as a cause of hospital admission in the elderly. Intern Med J 2001; 31: 199–205.

38.

Tamblyn

, McLeod

, Abrahamowicz

, et al. Questionable prescribing for elderly patients in Quebec. CMAJ 1994; 150: 1801–9.

39.

Burgess

, Holman

, Satti

. Adverse drug reactions in older Australians, 1981-2002. Med J Aust 2005; 182: 267–70.

40.

Kane-Gill

, Bos

JVD

, Handler

. Adverse drug reactions in hospital and ambulatory care settings identified using a large administrative database. Ann Pharmacother 2010; 44: 983–93. DOI: 10.1345/aph.1M726

41.

Gurwitz

, Avorn

. The ambiguous relation between aging and adverse drug reactions. Ann Intern Med 1991; 114: 956–66.

42.

Mangoni

, Jackson

SHD

. Age-related changes in pharmacokinetics and pharmacodynamics: basic principles and practical applications. Br J Clin Pharmacol 2004; 57: 6–14. DOI: 10.1046/j.1365-2125.2003.02007.x

43.

Jurrlink

, Preyra

, Croxford

, et al. Canadian Institute for Health Information discharge abstract database: a validation study. Toronto, Ontario: Institute for Clinical and Evaluative Sciences, 2006.

44.

. Adverse drug reactions in the emergency department population in Ontario: analysis of National Ambulatory Care reporting system and discharge abstract database 2003-2007.dverse drug reactions in the emergency department population in Ontario: analysis of National Ambulatory Care reporting system and discharge abstract database 2003-2007. University of Toronto, Ontario (Canada) ProQuest Dissertation and Theses, 2009. http://search.proquest.com/docview/89195004?accountid=12378 (accessed 2012 Jun 14).

45.

Leonard

, Haynes

, Localio

, et al. Diagnostic e-codes for commonly used, narrow therapeutic index medications poorly predict adverse drug events. J Clin Epidemiol 2008; 61: 561–71.